TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
756.00
+9.00 (1.20%)
At close: Mar 6, 2026

TELCON RF PHARMACEUTICAL. Revenue

TELCON RF PHARMACEUTICAL. had revenue of 9.82B KRW in the quarter ending September 30, 2025, with 37.17% growth. This brings the company's revenue in the last twelve months to 43.68B, up 18.20% year-over-year. In the year 2024, TELCON RF PHARMACEUTICAL. had annual revenue of 37.87B with 4.29% growth.

Revenue (ttm)
43.68B
Revenue Growth
+18.20%
P/S Ratio
0.62
Revenue / Employee
346.65M
Employees
126
Market Cap
27.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202437.87B1.56B4.29%
Dec 31, 202336.31B8.48B30.46%
Dec 31, 202227.83B-10.01B-26.46%
Dec 31, 202137.84B4.70B14.18%
Dec 31, 202033.14B-23.45B-41.44%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Humax 434.52B
Sungwoo Electronics 179.03B
Topco Media 40.38B
Itcencts 1,112.06B
EM-Tech.CO., LTD. 190.71B
MOBASE 1,360.86B
Huneed Technologies 50.05B
Ace Technologies 179.28B
Revenue Rankings